Matthew Winton
CIK 1971400 · View on SEC EDGAR ↗
First SEC filing: Feb. 13, 2026 · Latest: Feb. 13, 2026
On this page
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | CRVO | P | 1,500 | $7.95 | $11,925 | 15,000 Direct | +11.11% | Acquired | -67.8% (price as of 2026-08-21) |
| Nov. 17, 2025 | CRVO | P | 3,500 | $8.43 | $29,505 | 13,500 Direct | +35.00% | Acquired | -69.6% (price as of 2026-08-21) |
| Nov. 14, 2025 | CRVO | P | 10,000 | $7.57 | $75,700 | 10,000 Direct | — | Acquired | -66.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | CRVO | Stock Option (Right to Buy) | Common Stock (30,000) | $4.80 | Feb. 11, 2036 | 30,000 | Acquired |
| Oct. 6, 2025 | CRVO | Stock Option (Right to Buy) | Common Stock (75,000) | $8.62 | Oct. 6, 2035 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).